T2 Biosystems, Inc. (TTOO)
OTCMKTS
· Delayed Price · Currency is USD
0.1453
+0.0003 (0.21%)
May 13, 2025, 3:10 PM EDT
T2 Biosystems Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Cash & Equivalents | 15.69 | 10.33 | 22.25 | 16.79 | 11.03 | Upgrade
|
| Short-Term Investments | - | - | 10 | 25.4 | - | Upgrade
|
| Cash & Short-Term Investments | 15.69 | 10.33 | 32.24 | 42.19 | 11.03 | Upgrade
|
| Cash Growth | 51.89% | -67.96% | -23.58% | 282.39% | -78.28% | Upgrade
|
| Receivables | 1.42 | 2.16 | 5.13 | 5.1 | 2.83 | Upgrade
|
| Inventory | 4.82 | 4.29 | 3.91 | 3.64 | 3.6 | Upgrade
|
| Prepaid Expenses | 3.26 | 2.58 | 3.01 | 2.56 | 1.44 | Upgrade
|
| Other Current Assets | - | - | 0.1 | 0.1 | - | Upgrade
|
| Total Current Assets | 25.19 | 19.36 | 44.39 | 53.58 | 18.9 | Upgrade
|
| Property, Plant & Equipment | 9.05 | 13.27 | 14.44 | 14.81 | 9.21 | Upgrade
|
| Long-Term Investments | - | - | - | 10 | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 0.1 | - | Upgrade
|
| Other Long-Term Assets | 0.56 | 1.69 | 1.7 | 0.59 | 0.39 | Upgrade
|
| Total Assets | 34.8 | 34.33 | 60.54 | 79.08 | 28.49 | Upgrade
|
| Accounts Payable | 1.53 | 1.3 | 2.83 | 2.06 | 3.75 | Upgrade
|
| Accrued Expenses | 9.71 | 7.27 | 7.16 | 6.36 | 9.22 | Upgrade
|
| Current Portion of Long-Term Debt | 41.28 | - | - | - | 45.33 | Upgrade
|
| Current Portion of Leases | 1.62 | 1.35 | 1.17 | 1.15 | 1.98 | Upgrade
|
| Current Unearned Revenue | 0.22 | 0.17 | 0.52 | 0.23 | 0.29 | Upgrade
|
| Other Current Liabilities | 1.79 | 0.04 | - | - | - | Upgrade
|
| Total Current Liabilities | 56.15 | 10.13 | 11.69 | 9.8 | 60.57 | Upgrade
|
| Long-Term Debt | - | 49.65 | 47.79 | 46.25 | - | Upgrade
|
| Long-Term Leases | 6.6 | 8.21 | 9.36 | 10.53 | 1.87 | Upgrade
|
| Long-Term Unearned Revenue | 0.08 | 0.05 | 0.03 | 0.42 | 0.05 | Upgrade
|
| Other Long-Term Liabilities | - | 5.94 | 4.58 | 3.35 | - | Upgrade
|
| Total Liabilities | 62.83 | 73.98 | 73.44 | 70.35 | 62.49 | Upgrade
|
| Common Stock | 0 | - | 0 | 0.15 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 556.26 | 494.56 | 459.31 | 431.54 | 342.12 | Upgrade
|
| Retained Earnings | -584.3 | -534.22 | -472.22 | -422.98 | -376.18 | Upgrade
|
| Comprehensive Income & Other | - | - | -0 | 0.01 | - | Upgrade
|
| Total Common Equity | -28.04 | -39.66 | -12.9 | 8.73 | -34.01 | Upgrade
|
| Shareholders' Equity | -28.04 | -39.66 | -12.9 | 8.73 | -34.01 | Upgrade
|
| Total Liabilities & Equity | 34.8 | 34.33 | 60.54 | 79.08 | 28.49 | Upgrade
|
| Total Debt | 49.5 | 59.22 | 58.32 | 57.93 | 49.18 | Upgrade
|
| Net Cash (Debt) | -33.81 | -48.89 | -26.08 | -5.74 | -38.15 | Upgrade
|
| Net Cash Per Share | -12.95 | -958.53 | -820.91 | -236.46 | - | Upgrade
|
| Filing Date Shares Outstanding | 5.51 | 0.2 | 0.03 | 0.03 | 0.02 | Upgrade
|
| Total Common Shares Outstanding | 4.06 | 0.08 | 0.03 | 0.03 | 0.01 | Upgrade
|
| Working Capital | -30.96 | 9.23 | 32.71 | 43.78 | -41.68 | Upgrade
|
| Book Value Per Share | -6.91 | -513.90 | -387.71 | 294.64 | -3356.86 | Upgrade
|
| Tangible Book Value | -28.04 | -39.66 | -12.9 | 8.73 | -34.01 | Upgrade
|
| Tangible Book Value Per Share | -6.91 | -513.90 | -387.71 | 294.64 | -3356.86 | Upgrade
|
| Machinery | 12.1 | 13.54 | 14.59 | 11.84 | 13.18 | Upgrade
|
| Construction In Progress | 0.02 | 0.69 | 0.51 | 1.73 | 1.64 | Upgrade
|
| Leasehold Improvements | 3.61 | 3.78 | 3.77 | 3.69 | 3.5 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.